Patents Assigned to Galenica S.A.
  • 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives
    Patent number: 10513529
    Abstract: Derivatives of 1,2,4-Triazolo-[3,4-b]-1,3,4-thiadiazoles according to formula (I), as set forth below: processes for production thereof, pharmaceutical compositions containing the same and the use thereof in treatment of cancer.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: December 24, 2019
    Assignees: GALENICA S.A., ENERGONBIO TECHNOLOGIES S.A.
    Inventor: Dimitrios Trafalis
  • Esters of steroidal lactam and bis(2-chloroethyl) aminophenoxy propanoic acid derivatives
    Patent number: 10208083
    Abstract: Novel homo-aza-steroidal esters with alkylating bis(2-chloroethyl)aminophenoxy propanoic acid and substituted derivatives, processes for their preparation, pharmaceutical compositions containing them and use thereof in the treatment of cancer.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: February 19, 2019
    Assignees: Galenica S.A., Energonbio Technologies S.A.
    Inventor: Dimitrios Trafalis